FDA Releases Guidance for Industry on Communications with Payors and Formulary Committees

Summary

The US Food and Drug Administration (FDA) has published a guidance document answering common questions about communicating health care economic information to payors, formulary committees, and similar entities, as well as disseminating information about unapproved medical product uses.